Literature DB >> 34984173

Predicting primary outcomes of brain tumor patients with advanced neuroimaging MRI measures.

Svyat Vergun1, Josh I Suhonen2, Veena A Nair2, J S Kuo3, M K Baskaya3, Camille Garcia-Ramos1, Elizabeth E Meyerand4,5, Vivek Prabhakaran6.   

Abstract

BACKGROUND: Advanced neuroimaging measures along with clinical variables acquired during standard imaging protocols provide a rich source of information for brain tumor patient treatment and management. Machine learning analysis has had much recent success in neuroimaging applications for normal and patient populations and has potential, specifically for brain tumor patient outcome prediction. The purpose of this work was to construct, using the current patient population distribution, a high accuracy predictor for brain tumor patient outcomes of mortality and morbidity (i.e., transient and persistent language and motor deficits). The clinical value offered is a statistical tool to help guide treatment and planning as well as an investigation of the influential factors of the disease process.
METHODS: Resting state fMRI, diffusion tensor imaging, and task fMRI data in combination with clinical and demographic variables were used to represent the tumor patient population (n = 62; mean age = 51.2 yrs.) in a machine learning analysis in order to predict outcomes.
RESULTS: A support vector machine classifier with a t-test filter and recursive feature elimination predicted patient mortality (18-month interval) with 80.7% accuracy, language deficits (transient) with 74.2%, motor deficits with 71.0%, language outcomes (persistent) with 80.7% and motor outcomes with 83.9%. The most influential features of the predictors were resting fMRI connectivity, and fractional anisotropy and mean diffusivity measures in the internal capsule, brain stem and superior and inferior longitudinal fasciculi.
CONCLUSIONS: This study showed that advanced neuroimaging data with machine learning methods can potentially predict patient outcomes and reveal influential factors driving the predictions.

Entities:  

Keywords:  DTI; Machine-learning; Outcome prediction; Tumor patients; fMRI

Year:  2018        PMID: 34984173      PMCID: PMC8722581          DOI: 10.1016/j.inat.2018.04.013

Source DB:  PubMed          Journal:  Interdiscip Neurosurg        ISSN: 2214-7519


  22 in total

1.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Chaturia Rouse; Yanwen Chen; Jacqueline Dowling; Yingli Wolinsky; Carol Kruchko; Jill Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

Review 2.  Predicting language outcome and recovery after stroke: the PLORAS system.

Authors:  Cathy J Price; Mohamed L Seghier; Alex P Leff
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

3.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

Authors:  Bradford A Moffat; Thomas L Chenevert; Theodore S Lawrence; Charles R Meyer; Timothy D Johnson; Qian Dong; Christina Tsien; Suresh Mukherji; Douglas J Quint; Stephen S Gebarski; Patricia L Robertson; Larry R Junck; Alnawaz Rehemtulla; Brian D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

4.  Support vector machine classification and characterization of age-related reorganization of functional brain networks.

Authors:  Timothy B Meier; Alok S Desphande; Svyatoslav Vergun; Veena A Nair; Jie Song; Bharat B Biswal; Mary E Meyerand; Rasmus M Birn; Vivek Prabhakaran
Journal:  Neuroimage       Date:  2011-12-28       Impact factor: 6.556

5.  Prediction of individual brain maturity using fMRI.

Authors:  Nico U F Dosenbach; Binyam Nardos; Alexander L Cohen; Damien A Fair; Jonathan D Power; Jessica A Church; Steven M Nelson; Gagan S Wig; Alecia C Vogel; Christina N Lessov-Schlaggar; Kelly Anne Barnes; Joseph W Dubis; Eric Feczko; Rebecca S Coalson; John R Pruett; Deanna M Barch; Steven E Petersen; Bradley L Schlaggar
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

6.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

7.  Disease state prediction from resting state functional connectivity.

Authors:  R Cameron Craddock; Paul E Holtzheimer; Xiaoping P Hu; Helen S Mayberg
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

Review 8.  Impact of brain tumour treatment on quality of life.

Authors:  Jan J Heimans; Martin J B Taphoorn
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

9.  A baseline for the multivariate comparison of resting-state networks.

Authors:  Elena A Allen; Erik B Erhardt; Eswar Damaraju; William Gruner; Judith M Segall; Rogers F Silva; Martin Havlicek; Srinivas Rachakonda; Jill Fries; Ravi Kalyanam; Andrew M Michael; Arvind Caprihan; Jessica A Turner; Tom Eichele; Steven Adelsheim; Angela D Bryan; Juan Bustillo; Vincent P Clark; Sarah W Feldstein Ewing; Francesca Filbey; Corey C Ford; Kent Hutchison; Rex E Jung; Kent A Kiehl; Piyadasa Kodituwakku; Yuko M Komesu; Andrew R Mayer; Godfrey D Pearlson; John P Phillips; Joseph R Sadek; Michael Stevens; Ursina Teuscher; Robert J Thoma; Vince D Calhoun
Journal:  Front Syst Neurosci       Date:  2011-02-04

10.  Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.

Authors:  Maxwell Lewis Neal; Andrew D Trister; Tyler Cloke; Rita Sodt; Sunyoung Ahn; Anne L Baldock; Carly A Bridge; Albert Lai; Timothy F Cloughesy; Maciej M Mrugala; Jason K Rockhill; Russell C Rockne; Kristin R Swanson
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.